tanuxiciclib   Click here for help

GtoPdb Ligand ID: 11885

Synonyms: example 24 [WO2016126085A2]
Compound class: Synthetic organic
Comment: The chemical structure for tanuxiciclib was revealed in WHO proposed INN list 126 (Jan 2022), in which it was described as a cyclin dependent kinase inhibitor. It is one of the examples that are claimed in Beyond Bio's patent WO2016126085A2 [1]. In this patent data is provided for anti-proliferative activity against HCT116 human colon cancer cells.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 3
Rotatable bonds 2
Topological polar surface area 123.83
Molecular weight 312.11
XLogP 1.26
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Cc1nc(N)nc(c1)c1nc(ccc1O)c1ccnc(c1F)N
Isomeric SMILES Nc1nccc(c1F)c1nc(c(cc1)O)c1nc(nc(c1)C)N
InChI InChI=1S/C15H13FN6O/c1-7-6-10(22-15(18)20-7)13-11(23)3-2-9(21-13)8-4-5-19-14(17)12(8)16/h2-6,23H,1H3,(H2,17,19)(H2,18,20,22)
InChI Key UQHDKUFLWKTTDL-UHFFFAOYSA-N
Bioactivity Comments
Tanuxiciclib (example 24) demonstrates selectivity for CDK1, CDK2 and CDK5 comapred toCDKs 4 and 6 [1].
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
cyclin dependent kinase 1 Hs Inhibitor Inhibition 9.2 pIC50 - 1
pIC50 9.2 (IC50 6x10-10 M) [1]
Description: CDK1/cyclinD1
cyclin dependent kinase 5 Hs Inhibitor Inhibition 9.1 pIC50 - 1
pIC50 9.1 (IC50 7x10-10 M) [1]
Description: CDK5/p25
cyclin dependent kinase 2 Hs Inhibitor Inhibition 9.1 pIC50 - 1
pIC50 9.1 (IC50 9x10-10 M) [1]
Description: CDK2/cyclinE
cyclin dependent kinase 6 Hs Inhibitor Inhibition 7.5 pIC50 - 1
pIC50 7.5 (IC50 3.38x10-8 M) [1]
Description: CDK6/cyclinD
cyclin dependent kinase 4 Hs Inhibitor Inhibition 6.5 pIC50 - 1
pIC50 6.5 (IC50 3.415x10-7 M) [1]
Description: CDK3/cyclinD